caries
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Children who choose oral treatment; 2) Age 3-7 years old; 3) ASA Grade 1-2 patients
Exclusion criteria
Exclusion criteria: Previous volatile anesthetics allergies or sensitivities, high risk of malignant hyperthermia, recent respiratory and pulmonary infections, asthma attacks, nasal breathing disorders, pathological obesity, obstructive sleep apnea, nervous system diseases, metabolic diseases, hepatic and renal insufficiency, coagulation disorders, congenital heart disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 90% minimum effective end expiratory concentration of sevoflurane required for inhalation of anaesthetically induced nasal tracheal intubation in children undergoing oral therapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate; | — |
Countries
CHINA
Contacts
Beijing Millennium Temple Hospital affiliated to Capital Medical University